{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:10:10Z","timestamp":1774008610645,"version":"3.50.1"},"reference-count":106,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National Multiple Sclerosis Society"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple sclerosis is associated with lesions not just in the white matter, but also involving the cortex. Cortical involvement has been linked to greater disease severity and hence understanding the factor underlying cortical pathology could help identify new therapeutic strategies for multiple sclerosis. The critical role of B cells in multiple sclerosis has been clarified by multiple pivotal trials of B-cell depletion in people with multiple sclerosis. The presence of B-cell rich areas of meningeal inflammation in multiple sclerosis has been identified at all stages of multiple sclerosis. Leptomeningeal inflammation is associated with greater extent of cortical demyelination and neuronal loss and with greater disease severity. Recent studies have identified several potential mechanisms by which B cells may mediate cortical injury including antibody production, extracellular vesicles containing neurotoxic substances and production of pro-inflammatory cytokines. Additionally, B cells may indirectly mediate cortical damage through effects on T cells, macrophages or microglia. Several animal models replicate the meningeal inflammation and cortical injury noted in people with multiple sclerosis. Studies in these models have identified Bruton\u2019s tyrosine kinase inhibition and type II anti-CD20 antibodies as potential agents that can impact meningeal inflammation. Trials of anti-CD20 monoclonal antibodies in people with multiple sclerosis have unsuccessfully attempted to eliminate B cells in the leptomeninges. New strategies to target B cells in multiple sclerosis include Bruton\u2019s tyrosine kinase inhibition and cell-based therapies aimed at B cells infected with Epstein\u2013Barr virus. Future studies will clarify the mechanisms by which B cells mediate cortical injury and treatment strategies that can target B cells in the leptomeninges and CNS parenchyma.<\/jats:p>","DOI":"10.1093\/brain\/awac233","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T06:26:42Z","timestamp":1656656802000},"page":"3363-3373","source":"Crossref","is-referenced-by-count":36,"title":["Contribution of B cells to cortical damage in multiple sclerosis"],"prefix":"10.1093","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7947-9418","authenticated-orcid":false,"given":"Pavan","family":"Bhargava","sequence":"first","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[{"name":"Department of Neurology, Heinrich-Heine University , Dusseldorf , Germany"},{"name":"Brain and Mind Center, University of Sydney , Sydney , Australia"},{"name":"Department of Neurology, Medical University of Vienna , Vienna , Austria"},{"name":"Department of Neurology, Palacky University Olomouc , Olomouc , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A","family":"Calabresi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"2022112115242066100_awac233-B1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"2022112115242066100_awac233-B2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2377-12-10","article-title":"Clinical correlates of grey matter pathology in multiple sclerosis","volume":"12","author":"Horakova","year":"2012","journal-title":"BMC Neurol"},{"key":"2022112115242066100_awac233-B3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40263-014-0140-z","article-title":"Clinical relevance of brain volume measures in multiple sclerosis","volume":"28","author":"De Stefano","year":"2014","journal-title":"CNS Drugs"},{"key":"2022112115242066100_awac233-B4","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/brain\/aws189","article-title":"Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis","volume":"135","author":"Choi","year":"2012","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.22230","article-title":"A gradient of neuronal loss and meningeal inflammation in multiple sclerosis","volume":"68","author":"Magliozzi","year":"2010","journal-title":"Ann Neurol"},{"key":"2022112115242066100_awac233-B6","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","article-title":"Cellular immunology of relapsing multiple sclerosis: Interactions, checks, and balances","volume":"20","author":"Bar-Or","year":"2021","journal-title":"Lancet Neurol"},{"key":"2022112115242066100_awac233-B8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.25927","article-title":"Role of B cells in multiple sclerosis and related disorders","volume":"89","author":"Comi","year":"2021","journal-title":"Ann Neurol"},{"key":"2022112115242066100_awac233-B9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"2022112115242066100_awac233-B10","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/brain\/awy151","article-title":"The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells","volume":"141","author":"Machado-Santos","year":"2018","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B11","doi-asserted-by":"crossref","first-page":"e1108","DOI":"10.1212\/NXI.0000000000001108","article-title":"B cells in the CNS at postmortem are associated with worse outcome and cell types in multiple sclerosis","volume":"9","author":"Moccia","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2022112115242066100_awac233-B12","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B13","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/jnnp-2014-307712","article-title":"Multiple sclerosis deep grey matter: The relation between demyelination, neurodegeneration, inflammation and iron","volume":"85","author":"Haider","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022112115242066100_awac233-B14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-0-12-802395-2.00019-5","article-title":"Inflammatory demyelinating diseases of the central nervous system","volume":"145","author":"H\u00f6ftberger","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"2022112115242066100_awac233-B15","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N Engl J Med"},{"key":"2022112115242066100_awac233-B16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.25365","article-title":"Meningeal inflammation and cortical demyelination in acute multiple sclerosis","volume":"84","author":"Bevan","year":"2018","journal-title":"Ann Neurol"},{"key":"2022112115242066100_awac233-B17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2377-12-11","article-title":"Meningeal and cortical grey matter pathology in multiple sclerosis","volume":"12","author":"Popescu","year":"2012","journal-title":"BMC Neurol"},{"key":"2022112115242066100_awac233-B18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann Neurol"},{"issue":"Pt 4","key":"2022112115242066100_awac233-B19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2006","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00312463","article-title":"The significance of perivascular infiltrations in multiple sclerosis","volume":"211","author":"Guseo","year":"1975","journal-title":"J Neurol"},{"key":"2022112115242066100_awac233-B21","volume-title":"Multiple sclerosis [disseminated sclerosis]: An investigation by the association for research in nervous and mental disease","author":"Hassin","year":"1921"},{"key":"2022112115242066100_awac233-B22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol"},{"key":"2022112115242066100_awac233-B23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/nan.12199","article-title":"Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space","volume":"41","author":"Howell","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2022112115242066100_awac233-B24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00401-021-02274-7","article-title":"Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter","volume":"141","author":"Picon","year":"2021","journal-title":"Acta Neuropathol"},{"key":"2022112115242066100_awac233-B25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bpa.12841","article-title":"B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis","volume":"30","author":"Reali","year":"2020","journal-title":"Brain Pathol"},{"key":"2022112115242066100_awac233-B26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00401-021-02293-4","article-title":"Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration","volume":"141","author":"van Olst","year":"2021","journal-title":"Acta Neuropathol"},{"key":"2022112115242066100_awac233-B27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","article-title":"Microglia biology: One century of evolving concepts","volume":"179","author":"Prinz","year":"2019","journal-title":"Cell"},{"key":"2022112115242066100_awac233-B28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"2022112115242066100_awac233-B29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40478-020-00938-1","article-title":"Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration","volume":"8","author":"James","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"2022112115242066100_awac233-B30","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/brain\/awab045","article-title":"Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition","volume":"144","author":"Bhargava","year":"2021","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B31","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/jnnp-2011-300174","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"82","author":"Lucas","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022112115242066100_awac233-B32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science."},{"key":"2022112115242066100_awac233-B33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature."},{"key":"2022112115242066100_awac233-B34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","article-title":"Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: Implications for viral persistence and intrathecal B-cell activation","volume":"69","author":"Serafini","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"2022112115242066100_awac233-B35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12974-017-1049-5","article-title":"Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis","volume":"15","author":"Veroni","year":"2018","journal-title":"J Neuroinflammation"},{"key":"2022112115242066100_awac233-B36","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1212\/NXI.0000000000000466","article-title":"Molecular signature of Epstein-Barr virus infection in MS brain lesions","volume":"5","author":"Moreno","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"2022112115242066100_awac233-B37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1673-5374.245462","article-title":"The role of Epstein-Barr virus in multiple sclerosis: From molecular pathophysiology to in vivo imaging","volume":"14","author":"Guan","year":"2019","journal-title":"Neural Regen Res"},{"key":"2022112115242066100_awac233-B38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein\u2013Barr virus in multiple sclerosis: Theory and emerging immunotherapies","volume":"26","author":"Bar-Or","year":"2020","journal-title":"Trends Mol Med"},{"key":"2022112115242066100_awac233-B39","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","article-title":"Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain","volume":"132","author":"Willis","year":"2009","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B40","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","article-title":"Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis","volume":"74","author":"Sargsyan","year":"2010","journal-title":"Neurology"},{"key":"2022112115242066100_awac233-B41","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/jamaneurol.2015.1241","article-title":"Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in multiple sclerosis","volume":"72","author":"Harrison","year":"2015","journal-title":"JAMA Neurol"},{"key":"2022112115242066100_awac233-B42","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1093\/brain\/aws246","article-title":"Cortical lesion load associates with progression of disability in multiple sclerosis","volume":"135","author":"Calabrese","year":"2012","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B43","doi-asserted-by":"crossref","first-page":"S44.001","DOI":"10.1212\/WNL.82.10_supplement.S44.001","article-title":"Leptomeningeal contrast enhancement in multiple sclerosis: A possible marker of inflammation in the subarachnoid space (S44.001)","volume":"82","author":"Reich","year":"2014","journal-title":"Neurology"},{"key":"2022112115242066100_awac233-B44","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0000000000003820","article-title":"Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases","volume":"88","author":"Absinta","year":"2017","journal-title":"Neurology"},{"key":"2022112115242066100_awac233-B45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1352458519892186","article-title":"Controversial association between leptomeningeal enhancement and demyelinated cortical lesions in multiple sclerosis","volume":"26","author":"Absinta","year":"2020","journal-title":"Mult Scler"},{"key":"2022112115242066100_awac233-B46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.0000000000001587","article-title":"Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis","volume":"85","author":"Absinta","year":"2015","journal-title":"Neurology"},{"key":"2022112115242066100_awac233-B47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1352458519885106","article-title":"7 T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions","volume":"26","author":"Zurawski","year":"2020","journal-title":"Mult Scler"},{"key":"2022112115242066100_awac233-B48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jon.12444","article-title":"Leptomeningeal enhancement at 7 T in multiple sclerosis: frequency, morphology, and relationship to cortical volume","volume":"27","author":"Harrison","year":"2017","journal-title":"J Neuroimaging"},{"key":"2022112115242066100_awac233-B49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1352458519876037","article-title":"No association between cortical lesions and leptomeningeal enhancement on 7-tesla MRI in multiple sclerosis","volume":"26","author":"Ighani","year":"2020","journal-title":"Mult Scler"},{"key":"2022112115242066100_awac233-B50","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.25197","article-title":"Inflammatory intrathecal profiles and cortical damage in multiple sclerosis","volume":"83","author":"Magliozzi","year":"2018","journal-title":"Ann Neurol"},{"key":"2022112115242066100_awac233-B51","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/13524585211032510","article-title":"Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients","volume":"28","author":"Pitteri","year":"2022","journal-title":"Mult Scler"},{"key":"2022112115242066100_awac233-B52","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/brain\/awv011","article-title":"A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging","volume":"138","author":"Mainero","year":"2015","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B53","doi-asserted-by":"crossref","first-page":"eabf9277","DOI":"10.1126\/science.abf9277","article-title":"Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders","volume":"373","author":"Brioschi","year":"2021","journal-title":"Science"},{"key":"2022112115242066100_awac233-B54","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/brain\/awq350","article-title":"Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis","volume":"134","author":"Lovato","year":"2011","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2017.05.004","article-title":"B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro","volume":"309","author":"Lisak","year":"2017","journal-title":"J Neuroimmunol"},{"key":"2022112115242066100_awac233-B56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.02.015","article-title":"Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro","volume":"246","author":"Lisak","year":"2012","journal-title":"J Neuroimmunol"},{"key":"2022112115242066100_awac233-B57","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1212\/NXI.0000000000000550","article-title":"Exosome-enriched fractions from MS B cells induce oligodendrocyte death","volume":"6","author":"Benjamins","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"2022112115242066100_awac233-B58","doi-asserted-by":"crossref","DOI":"10.1177\/1849454419879848","article-title":"Lipidomic characterization of extracellular vesicles in human serum","volume":"8","author":"Chen","year":"2019","journal-title":"J Circ Biomark"},{"key":"2022112115242066100_awac233-B59","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/brain\/awu139","article-title":"Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics","volume":"137","author":"Vidaurre","year":"2014","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","article-title":"Neurotoxic reactive astrocytes induce cell death via saturated lipids","volume":"599","author":"Guttenplan","year":"2021","journal-title":"Nature"},{"key":"2022112115242066100_awac233-B61","doi-asserted-by":"crossref","first-page":"310ra166","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci Transl Med"},{"key":"2022112115242066100_awac233-B62","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann Neurol"},{"key":"2022112115242066100_awac233-B63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/dneu.20584","article-title":"Effect of astrocyte-targeted production of IL-6 on traumatic brain injury and its impact on the cortical transcriptome","volume":"68","author":"Quintana","year":"2008","journal-title":"Dev Neurobiol"},{"key":"2022112115242066100_awac233-B64","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/jnr.21620","article-title":"Ciliary neurotrophic factor and interleukin-6 differentially activate microglia","volume":"86","author":"Krady","year":"2008","journal-title":"J Neurosci Res"},{"key":"2022112115242066100_awac233-B65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainresrev.2011.01.002","article-title":"Interleukin-6, a mental cytokine","volume":"67","author":"Spooren","year":"2011","journal-title":"Brain Res Rev"},{"key":"2022112115242066100_awac233-B66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2004.06.014","article-title":"Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures","volume":"155","author":"Conroy","year":"2004","journal-title":"J Neuroimmunol"},{"key":"2022112115242066100_awac233-B67","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/cdd.2009.179","article-title":"The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis","volume":"17","author":"Centonze","year":"2010","journal-title":"Cell Death Differ"},{"key":"2022112115242066100_awac233-B68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12974-019-1650-x","article-title":"Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis","volume":"16","author":"Magliozzi","year":"2019","journal-title":"J Neuroinflammation"},{"key":"2022112115242066100_awac233-B69","doi-asserted-by":"crossref","first-page":"10306","DOI":"10.1073\/pnas.1222895110","article-title":"Peripheral elevation of TNF-\u03b1 leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis","volume":"110","author":"Yang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022112115242066100_awac233-B70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/brain\/awv353","article-title":"Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis","volume":"139","author":"J\u00fcrgens","year":"2016","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B71","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00401-015-1500-6","article-title":"Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants","volume":"130","author":"Blauth","year":"2015","journal-title":"Acta Neuropathol"},{"key":"2022112115242066100_awac233-B72","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1073\/pnas.1518553113","article-title":"Anoctamin 2 identified as an autoimmune target in multiple sclerosis","volume":"113","author":"Ayoglu","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022112115242066100_awac233-B73","doi-asserted-by":"crossref","first-page":"21512","DOI":"10.1073\/pnas.2011249117","article-title":"Autoantibodies against central nervous system antigens in a subset of B cell-dominant multiple sclerosis patients","volume":"117","author":"Kuerten","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022112115242066100_awac233-B74","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jnen\/64.2.147","article-title":"The pathology of multiple sclerosis is location-dependent: No significant complement activation is detected in purely cortical lesions","volume":"64","author":"Brink","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"2022112115242066100_awac233-B75","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jneuroim.2003.10.056","article-title":"Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis","volume":"148","author":"Magliozzi","year":"2004","journal-title":"J Neuroimmunol"},{"key":"2022112115242066100_awac233-B76","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.immuni.2015.11.010","article-title":"Integration of Th17- and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation","volume":"43","author":"Pikor","year":"2015","journal-title":"Immunity"},{"key":"2022112115242066100_awac233-B77","doi-asserted-by":"crossref","first-page":"e132522","DOI":"10.1172\/jci.insight.132522","article-title":"Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury","volume":"5","author":"Ward","year":"2020","journal-title":"JCI Insight"},{"key":"2022112115242066100_awac233-B78","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1212\/NXI.0000000000000975","article-title":"Anti-CD20 disrupts meningeal B-cell aggregates in a model of secondary progressive multiple sclerosis","volume":"8","author":"Roodselaar","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"2022112115242066100_awac233-B79","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC Class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J Exp Med"},{"key":"2022112115242066100_awac233-B80","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/brain\/awh626","article-title":"Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis","volume":"128","author":"Pomeroy","year":"2005","journal-title":"Brain"},{"key":"2022112115242066100_awac233-B81","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/cercor\/bhaa235","article-title":"Ultrahigh-resolution MRI reveals extensive cortical demyelination in a nonhuman primate model of multiple sclerosis","volume":"31","author":"Donadieu","year":"2021","journal-title":"Cereb Cortex"},{"key":"2022112115242066100_awac233-B82","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/bpa.12180","article-title":"Increased meningeal T and plasma cell infiltration is associated with early subpial cortical demyelination in common marmosets with experimental autoimmune encephalomyelitis","volume":"25","author":"Kramann","year":"2015","journal-title":"Brain Pathol"},{"key":"2022112115242066100_awac233-B83","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N Engl J Med"},{"key":"2022112115242066100_awac233-B84","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ana.21867","article-title":"Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial","volume":"66","author":"Hawker","year":"2009","journal-title":"Ann Neurol"},{"key":"2022112115242066100_awac233-B85","doi-asserted-by":"crossref","first-page":"e918","DOI":"10.1212\/NXI.0000000000000918","article-title":"Targeting B cells to modify MS, NMOSD, and MOGAD: Part 1","volume":"8","author":"Graf","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"2022112115242066100_awac233-B86","doi-asserted-by":"crossref","first-page":"e1854","DOI":"10.1212\/WNL.0000000000010376","article-title":"Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension","volume":"95","author":"Hauser","year":"2020","journal-title":"Neurology"},{"key":"2022112115242066100_awac233-B87","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(20)30342-2","article-title":"Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: A post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial","volume":"19","author":"Wolinsky","year":"2020","journal-title":"Lancet Neurol"},{"key":"2022112115242066100_awac233-B88","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/10428194.2012.718342","article-title":"Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder","volume":"54","author":"Czyzewski","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"2022112115242066100_awac233-B89","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2006.09.7311","article-title":"Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma","volume":"25","author":"Rubenstein","year":"2007","journal-title":"J Clin Oncol"},{"key":"2022112115242066100_awac233-B90","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.msard.2019.02.013","article-title":"Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement","volume":"30","author":"Bhargava","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"2022112115242066100_awac233-B91","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/acn3.293","article-title":"Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis","volume":"3","author":"Komori","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"2022112115242066100_awac233-B92","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1212\/NXI.0000000000000079","article-title":"Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally","volume":"2","author":"Svenningsson","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"2022112115242066100_awac233-B93","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.msard.2016.01.001","article-title":"The effects of intrathecal rituximab on biomarkers in multiple sclerosis","volume":"6","author":"Topping","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"2022112115242066100_awac233-B94","first-page":"8813498","article-title":"No early effect of intrathecal rituximab in progressive multiple sclerosis (EFFRITE clinical trial)","volume":"2021","author":"Bonnan","year":"2021","journal-title":"Mult Scler Int"},{"key":"2022112115242066100_awac233-B95","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.msard.2018.09.025","article-title":"Leptomeningeal inflammation in multiple sclerosis: Insights from animal and human studies","volume":"26","author":"Wicken","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"2022112115242066100_awac233-B96","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(21)00250-7","article-title":"BTK Inhibitors as potential therapies for multiple sclerosis","volume":"20","author":"Correale","year":"2021","journal-title":"Lancet Neurol"},{"key":"2022112115242066100_awac233-B97","doi-asserted-by":"crossref","first-page":"85834","DOI":"10.1371\/journal.pone.0085834","article-title":"Btk regulates macrophage polarization in response to lipopolysaccharide","volume":"9","author":"Gabhann","year":"2014","journal-title":"PLoS ONE"},{"key":"2022112115242066100_awac233-B98","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-020-02204-z","article-title":"Inhibition of Bruton\u2019s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease","volume":"140","author":"Torke","year":"2020","journal-title":"Acta Neuropathol"},{"key":"2022112115242066100_awac233-B99","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1474-4422(21)00237-4","article-title":"Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: A phase 2b, randomised, double-blind, placebo-controlled trial","volume":"20","author":"Reich","year":"2021","journal-title":"Lancet Neurol"},{"key":"2022112115242066100_awac233-B100","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1901981","article-title":"Placebo-controlled trial of an oral BTK inhibitor in multiple sclerosis","volume":"380","author":"Montalban","year":"2019","journal-title":"N Engl J Med"},{"key":"2022112115242066100_awac233-B101","doi-asserted-by":"crossref","first-page":"e1117","DOI":"10.1212\/NXI.0000000000001117","article-title":"Siponimod inhibits the formation of meningeal ectopic lymphoid tissue in experimental autoimmune encephalomyelitis","volume":"9","author":"Brand","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"2022112115242066100_awac233-B102","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/j.seminhematol.2010.01.001","article-title":"CD20 as a target for therapeutic type I and II monoclonal antibodies","volume":"47","author":"Beers","year":"2010","journal-title":"Semin Hematol"},{"key":"2022112115242066100_awac233-B103","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1182\/blood-2010-01-263533","article-title":"Antigenic modulation limits the efficacy of anti-CD20 antibodies: Implications for antibody selection","volume":"115","author":"Beers","year":"2010","journal-title":"Blood"},{"key":"2022112115242066100_awac233-B104","doi-asserted-by":"crossref","first-page":"e124714","DOI":"10.1172\/jci.insight.124714","article-title":"Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis","volume":"3","author":"Pender","year":"2018","journal-title":"JCI Insight"},{"key":"2022112115242066100_awac233-B105","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N Engl J Med"},{"key":"2022112115242066100_awac233-B106","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMc2107725","article-title":"CD19-targeted CAR T cells in refractory systemic lupus erythematosus","volume":"385","author":"Mougiakakos","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awac233\/45250261\/awac233.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/10\/3363\/47162801\/awac233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/10\/3363\/47162801\/awac233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T03:54:22Z","timestamp":1727495662000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/145\/10\/3363\/6623951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":106,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,7,1]]},"published-print":{"date-parts":[[2022,10,21]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awac233","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742218932.793594038","asserted-by":"object"}]},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,3]]},"published":{"date-parts":[[2022,7,1]]}}}